Patent · US Active

Quinoxaline compounds

US7563895B2 · kind B2 · utility

0Cited by

6References

2Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Brett D. Allison · Del Mar, US
Michael D. Hack · San Diego, US
Victor K. Phuong · San Diego, US
Michael H. Rabinowitz · San Diego, US
Mark D. Rosen · San Diego, US

Key dates

Filing date	Dec 4, 2007
Grant date	Jul 21, 2009
Priority date	—
Expiry date	Dec 4, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain amidophenyl-sulfonylamino-quinoxaline compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.